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Summarymn i i ^ -  whim j
The effect of pancuronium pretreatment on the function of the prejunctional 
muscarinic receptor in guinea-pig trachea was studied by using electrical field f 
stimulation (EFS). The effects of cumulative doses of the muscarinic M2 receptor 
antagonist gallamine were investigated in tracheal smooth muscle strips from 
guinea-pigs after addition of pancuronium in vitro and in strips from guinea-pigs 
which had been pretreated with doses of pancuronium that caused 100% 
neuromuscular blockade. The results of both types of experiments were 
compared to those of control groups of the same size. In all strips a dose 
response curve with cumulative doses of methacholine was made before EFS was 
switched on. No differences were found between the mean pD2 value and slope 
of the concentration-response curves of untreated guinea-pigs and animals treated 
with anaesthetics and pancuronium. The animals showed variable responses to 
pancuronium. The bath concentration of pancuronium which decreased the EFS- 
induced contraction to half the original value varied between 14-61 pM. The 
intravenous dose necessary to paralyze the muscles, varied among the different 
guinea-pigs from 0,017 - 0.085 mg*kg’1. The EFS-induced contraction for the 
concentration range of gallamine 0,32 pM - 0.32 niM was found to differ 
significantly between the strips treated with pancuronium in the organ bath and 
their control group. For the guinea-pigs anaesthetized and pretreated with 
pancuronium a significant difference with control was observed at gallamine 
concentrations ranging from 0.032 - 0.32 mM. These results show that 
pancuronium, added to the organ bath as well as administered intravenously to 
the guinea-pig, masked the inhibitory muscarinic receptor.
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Prejunctional muscarinic autoreceptors have been demonstrated in functional and release
experiments in different species like cats (1), rats (2), guinea-pigs (3-7), dogs (8) and man (4).
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The prejunctional autoreceptor has been characterized with selective muscarinic antagonists, and 
appeared to be an Mr like receptor, which differs in the guinea-pig from the cardiac type M2 
receptor in its relatively high affinity for hexahydrosiladiphenidol (6),
Prejunctional muscarinic autoreceptors in human airways are of special interest, as they might 
play a role in the etiology of asthma (9). The first evidence for the presence and functionality 
of prejunctional muscarinic autoreceptors in human airways came from a study in which 
pilocarpine and gallamine were used as selective agents to demonstrate the prejunctional 
autoreceptor in electrical field stimulation (EFS) experiments (4), Although one may question 
the usefulness of pilocarpine as a selective agonist in this approach (5), the possibility of a role 
of an inhibitory muscarinic receptor in human airways is important enough to perform further 
investigation.
In a subsequent study at our laboratory, with human bronchial smooth muscle obtained during 
lung surgery, however, no evidence was found for the presence of the prejunctional inhibitory 
muscarinic receptor with selective M2 antagonists (10). We therefore evaluated whether the 
specific conditions of lung surgery and in particular the various anaesthetic and neuromuscular 
blocking drugs used, may have caused the neuronal M2 receptor response to vanish. Specific 
attention was drawn to pancuronium, as pilot experiments had excluded the possible influence 
of halothane inhalation and intubation,
This study uses two different experimental approaches. In the in vitro experiments it is shown 
that incubation with pancuronium in the organ bath can cause the effect of gallamine on the 
inhibitory muscarinic receptor to vanish. In the second experimental approach clinical 
conditions were mimicked. Doses of pancuronium which caused complete muscle relaxation 
were administered intravenously. Tracheal smooth muscle strips of the animals did not show 
any effect of gallamine on the inhibitory muscarinic receptors.
Methods
A nim als
Healthy Dunkin-Hartley guinea-pigs of either sex (450-800 g, Harlan C.P.B., Zeist, The
Netherlands) were used for the experiments. Pre-experimental conditions were standardized,
including manufactured food and tap-water ad libitum, housing conditions, 12-h light-dark
cycles with white light on at 08.00 a.m. and an environmental temperature of 21°C. The
experiments were also performed at an environmental temperature of 21°C. Each guinea-pig 
was studied only once.
Anaesthesia
Anaesthesia was induced by inhalation of halothane in a mixture of air:oxygen (1:1). Once the 
animal stopped responding to external stimulation, the trachea was intubated, Anaesthesia was 
maintained with inhalation of halothane by a semi-open electrical-valve-controlled small-animal 
ventilator connected to the endotracheal cannula (Abbocath™ 14 gauge i.v. catheter), which 
was used for artificial nor mo ventilation at a constant fresh gas flow of 0.5 ml-min'^g'1 body 
weight. For experiments under the same conditions in rodents of comparative weights it was 
found that such a minute volume resulted in a PaCOl of 4.5 - 5.0 kPa (11).
The left jugular vein was cannulated to allow the administration of drugs. The left tibialis 
anterior muscle tendon was freed, sectioned near its attachment and connected to a Ft03C Grass
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force-displaccment transducer. Twitch contractions were elicited by supramaximal stimulation 
of the proximally cut sciatic nerve on the same side. The (rectangular block) single stimuli 
were delivered by a Grass S I1 stimulator at a rate of 0.1 Hz with a duration of 0.2 ms. The 
resting tension was adjusted to 15 g. Rectal temperatures were maintained between 37 and 
38°C. The quantitated responses were recorded on a Thermal Array multichannel recorder 
together with the heart rate, which was recorded from the carotid artery.
In vitro pancuronium experiments
Guinea-pigs were killed by cervical dislocation, without the administratiun of anaesthetics. The 
trachea was dissected free from connective tissue and tracheal smooth muscle strips (two 
cartilage rings, strip length: 10 mm x 3 mm) were prepared in Krebs-Henseleit (KH) buffer. 
The composition of KH (in mM) was as follows: NaCl, 118.4; KC1, 4.7; MgS04, 0.6; KH2P04,
1,2; NaHC03, 25.0; CaCl2, 2.5; glucose, l i . l ,  continuously gassed with a mixture of 5% C02 
and 95% 0 2 in order to maintain oxygen tension and a pH of 7.4 at 37°C. Immediately after 
preparation, the strips were mounted between two platinum electrodes (above and under the 
preparation) in 10 ml organ baths (KH, 37°C) under isotonic recording with a preload of 0.25 
g ,  After a 60-min equilibration period with five intermediate changes of buffer solution, a 
steady baseline was reached.
Cumulative doses of methacholine were added to the organ bath and the contraction of the 
tracheal strip was recorded. After a washing out period of 60 min, electrical field stimulation 
(EFS) was started, delivered by a Grass S48 stimulator. Every 100 s the strip was stimulated by 
a train of pulses with the following parameters: frequency 32 Hz; Grass reading voltage 70 V 
(voltage between the electrodes 15 V); pulse duration 0.5 ms and train duration 10 s. After a 
minimum period of 60 min, EFS-induced contraction height had become constant and 
pancuronium was added to the bath in cumulative doses until the contraction had decreased to 
50% of its initial value (range of final bath concentration: 14-61 \xM). When the EFS-induced 
contraction had been stable for at least 15 min, cumulative doses of gallaminc were added with 
steps of 0.5 logarithmic units. Doses of gallamine were given when the EFS-induced 
contraction was stabilized. In the absence of a change the next dose was added after 15 min. 
When EFS-induced contraction height had decreased to 25% of its value before adding 
gallamine, EFS was stopped and the antagonist was washed out during 60 min. Thereafter, 
maximal contraction was determined with methacholine and maximal relaxation with 
isoproterenol (bath concentration: 10 jliM) and EDTA (bath concentration: 3.2 mM). Four 
smooth muscle strips of four guinea-pigs were handled this way.
In vivo pancuronium experiments
Aliquots of pancuronium were administered intravenously at 5 min intervals until the twitch 
response of the tibialis anterior muscle was depressed completely. In pilot studies it had been 
assessed that once twitch contractions were completely depressed, this effect would last for at 
least 60 min. After a period of 45 min of complete muscle relaxation, the anaesthetized guinea- 
pig was removed from the ventilator and killed directly by cervical dislocation. Subsequently 
the trachea was freed, the smooth muscle strips were prepared and suspended in the organ 
baths, where they were treated according to the method described above. After the washing 
period and the addition of cumulative doses of methacholine, methacholine was washed out and 
EFS was started. When EFS-induced contraction had been stable for at least 15 min, cumulative 
doses gallamine were added with steps of 0.5 logarithmic units. Doses of gallamine were given 
when the EFS-induced contraction response was stabilized. In the absence of a change the next 
dose was added after 15 min. Each of the six smooth muscle strips of the six guinea-pigs was 
treated this way.
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Control experiments
For both types of experiments a control group was studied. Each was composed of animals of a 
similar weight and housed under identical conditions as the test group. These guinea-pigs were 
not anaesthetized, but were killed immediately by cervical dislocation. To verify whether 
gallamine enhances the EFS-induced contraction response during 50% postsynaptic receptor 
blockade, four control experiments were done with the M r selective antagonist 4-DAMP. 
Similar to the in vitro pancuronium experiments, 4-DAMP was added to the bath until 
contraction was reduced to 50% of its initial value (final bath concentration 0.8 - 1.0 nM), 
whereafter the effect of increasing gallamine concentrations was measured.
To characterize the EFS-induced contraction response, the sodium channel blocking agent 
tetrodotoxin (bath concentration: 1 pM), the muscarinic antagonist atropine (bath concentration:
1 pM) or the nicotinic ganglion blocking drug hexamethonium (bath concentration: 10 pM) 
were added to four different tracheal smooth muscle strips of four different guinea-pigs.
Drugs
Gallamine triethiodide, tetrodotoxin and atropine sulphate were obtained from Sigma Chemical 
Co (St. Louis, MO, USA). Acetyl-ß-methylcholine chloride (methacholine) was obtained from 
Janssen Chimica (Beerse, Belgium). Hexamethonium iodide was purchased from Fluka (Buchs, 
Switzerland), pancuronium bromide from Organon Teknika (Boxtel, The Netherlands), 4- 
DAMP (4-diphenylacetoxy-N-methylpiperidine methiodode) from Research Biochemicals 
International (Natick, MA, USA) and isoproterenol from Lansberg (Uden, The Netherlands). 
Chemical agents were of analytical grade. All drugs for the in vitro studies were prepared daily 
in Krebs-Henseleit buffer. Pancuronium bromide used in vivo was dissolved in 0.9% saline.
Data analysis and statistics
The relative EFS-induced contraction height was defined as the measured EFS-induced 
contraction height (Hm) divided by EFS-induced contraction height before any addition of anta­
gonist (Hcj. Methacholine pD2 values were calculated by using GraphPAD version 4.03 
(GraphPAD Software Inc., San Diego, CA, U.S.A.). All values are given as mean ± SEM. At 
each bath concentration of gallamine the values of the relative EFS-induced contraction height 
with and without addition or administration of pancuronium were compared using Student's t- 
test for independent samples. In all experiments, n represents the number of guinea-pigs 
studied. Differences were considered to be statistically significant when /J<0.05.
Results
Response to methacholine
The mean pD2 for methacholine in the airway smooth muscle strips from anaesthetized guinea- 
pigs treated with pancuronium was 5.68 ± 0.11 (n = 6), with a slope of the concentration- 
response curve of 0.65 ± 0.02 (n = 6, significantly different from 1). The mean pD2 for 
methacholine in the strips of the guinea-pigs that were not anaesthetized and not treated with 
pancuronium was 5.46 ± 0.15 (n = 10), with a slope of 0.70 ± 0.04 (n = 10, significantly 
different from 1). The difference between the two groups was not significant. Although 
methacholine is susceptible to the action of cholinesterase, the lack of difference between the 
groups was not affected by inclusion of physostigmine (results not shown), in the in vitro 
experiments, the concentration-response curve to methacholine was shifted 0.58 ±0.13 {n = 4) 
logarithmic units to the right in presence of 14 pM pancuronium, whereas the maximal 
response remained unaffected.
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Characterization of the EFS-induced contraction
EFS-induced contractions were blocked completely by atropine at a bath concentration of 1 jaM. 
Hexamethonium had no effect at a bath concentration up to 10 jjM, whereas tetrodotoxin 
completely inhibited the EFS-induced contractions at a bath concentration of i jliM.
Influence of in vitro incubation with pancuronium on the effect of gallamine 
In the absence of pancuronium, gallamine (3.2 nM - 1 mM) causes an increase of the EFS- 
induced contraction of the smooth muscle strips (Fig. 1). In the presence of pancuronium in the 
bath (14 - 61 jliM) the increase of the EFS-induced contraction by gallamine is vanished. The 
differences are significant at the following bath concentrations: 0.32 \xM (P<0,05), 1 - 32 juM 
(all: PcO.Ol), 0.1 mM (P<0.02), 0.32 mM (P<0.05). When contraction was reduced to half its 
initial value with 4-DAMP (0.8 - 1.0 nM), relative contraction responses significantly larger 
than 1 were observed at gallamine concentrations ranging from 0.032 - 0.32 mM, with the 
highest value of 1.72 ±0.13 at 0.32 mM. The results indicate that under these conditions 
gallamine still potentiates the EFS-induced contraction. Pancuronium alone produced an effect 
similar to gallamine on EFS-induced contraction. Maximal potentiation of the relative 
contraction response by 1.20 ± 0.06 (/MX05, n = 8) was observed at a bath concentration of I
pM.
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Fig. 1
The effect of gallamine on EFS induced contraction of smooth muscle strips of 
guinea-pig trachea in presence of pancuronium, at a concentration which caused 
50% inhibition of the EFS induced contraction. The points represent the relative 
contraction (Hm He'1, y-axis) at a certain gallamine concentration (bath 
concentration in M, logarithmic scale, x-axis). Hm = measured EFS induced 
contraction height; He = control EFS induced contraction height i.e. before 
addition of gallamine; C = control value: without addition of gallamine. Closed 
symbols correspond to strips in presence of pancuronium in the organ bath, open 
symbols indicate strips of the control group. Both groups consisted of four 
smooth muscle strips of four different animals (*ƒ*<0.05)
Influence of in vivo administration of pancuronium on the effect of gallamine 
The intravenous dose of pancuronium that caused complete muscle relaxation in the animals 
varied within the range of 0.017 - 0.085 mg’kg“1. From a representative experiment the effect as 
a function of time after intravenous administration of pancuronium is shown in Fig. 2. In the
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untreated animals, gallamine (3.2 nM - I mM) causes an increase of the EFS-incta 
contraction of airway smooth muscle strips (Fig. 3). In the pancuronium treated animals 
increase of the EFS-induced contraction hy gallamine is vanished. The differences 
significant at the following bath concentrations: 32 |.iM (,/J<0 .02), 0.1 mM (/'<().01), 0.32 n
(P< 0.02).
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The ellect ol gallamine on the EFS induced contraction of tracheal smooth
musclc strips from guinea-pigs pretreated with pancuronium intravenously. The
points represent the relative contraction (Hm Hc'\ y-axis) in the presence of
gallamine (bath concentration in M, logarithmic scale, x-axis). Hm = measured
EFS induced contraction height; He = control EFS induced contraction height
i.e. before addition of gallamine; C = control value: without addition of
gallamine. Closed symbols correspond to strips from guinea-pigs which were
pretreated with pancuronium intravenously, open symbols indicate strips of the
controls. Both groups consisted of six smooth muscle strips of six different 
animals (*P<0.05)
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Discussion
In the experimental setup we have chosen two approaches. In the in vitro approach we 
applied a concentration of pancuronium which caused a 50% blockade of the postsynaptic 
muscarinic receptor. Based on a 10- to 100-fold greater antagonist potency of pancuronium for 
muscarinic M2 receptors in the heart compared to its potency on M3 receptors in ileal smooth 
muscle (12), we assumed that at the concentration used an almost complete blockade of the 
prejunctional muscarinic receptors occurs. The concentration of pancuronium in the organ bath 
is well defined, but the clinical circumstances are mimicked incompletely. In the in vivo 
approach, which most clearly mimics the clinical situation, a critical dose of pancuronium could 
be chosen which causes complete relaxation of the skeletal muscle. The concentration of 
pancuronium in the receptor compartment after preparation of the smooth muscle strip, 
suspension in the organ bath, equilibration and washings and methacholine dose response 
curves are less defined.EFS-induced contraction of smooth muscle strips was blocked for at 
least 90% by the sodium channel blocking agent tetrodotoxin. Thus, EFS-induced response was 
completely nerve-stimulated and did not result from a direct activation of neural varicosities or 
endplates without nerve conduction (13). Since EFS-induced contractions were completely 
blocked by the muscarinic antagonist atropine (bath concentration: 1 pM) and not influenced by 
the nicotinergic ganglion blocking drug hexamethonium (bath concentration: 10 pM), it may be 
concluded that the EFS-induced contraction with parameters as described, is mainly due to 
postganglionic, cholinergic stimulation. However, guinea-pig tracheal smooth muscles receive a 
dual innervation from both the parasympathetic and sympathetic nervous system and evidence 
exist for cross talk between the two neuronal systems (14-16).
Blockade of prejunctional inhibitory muscarinic rcccptors by selective antagonists will result in 
EFS experiments in an increased release of acetylcholine, which can be measured as an 
increased EFS-induced contraction, as is demonstrated in the control experiments with 
gallamine (the 'gallamine effect') in Figs. 1 and 3. A decrease in EFS-induced contraction can 
be explained by a postjunctional blockade of muscarinic receptors located on the smooth 
muscle. This postjunctional blockade occurs at high gallamine concentrations. The present study 
shows that the response of the inhibitory muscarinic receptor in guinea-pig trachea vanishes 
when pancuronium was used during anaesthesia. These data and their clinical relevance are 
discussed further.
Pancuronium is known for its nondepolarizing neuromuscular blocking action. Besides this 
action an effect on muscarinic receptors (17) and a cocaine-like action (18) are described. This 
latter autonomic effect of pancuronium might explain the observed suppression of the 
'gallamine effect' as the parasympathetic nerve endings in the guinea-pig trachea contain 
inhibiting muscarinic as well as inhibiting adrenergic receptors (15). A more direct explanation 
for the observed suppression of the gallamine effect by pancuronium is its effect on the 
inhibitory muscarinic receptor.
Pancuronium has been classified as an antagonist of cardiac M2 muscarinic receptors, based on 
findings in the pithed rat and organ bath experiments with rat isolated atria preparation. Binding 
of [?H] quinuclidlnyl benzilate to cardiac M2 muscarinic receptors of the rat was inhibited by 
classical muscarinic antagonists but also by nicotinic blocking agents and by inhibitors of 
acetylcholinesterase (19). Gallamine and pancuronium were among the most potent of the 
examined agents, they showed no agonist activity but, like atropine, completely antagonized 
muscarinic receptor-mediated inhibition of cyclic AMP formation. From in vivo experiments it 
was concluded that pancuronium and gallamine are antagonists for prejunctional M2 and
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postjunctional M3 muscarinic receptors in the guinea-pig (12). Both agents potentiated vagally- 
induced bronchoconstriction. In our in vivo guinea-pig experiments, no measurable amounts 
(<0.08 ng/mg tissue) of pancuronium were found in homogenates of smooth muscle strips 
following the washing procedure, as determined with HPLC (results not shown). Although one 
could speculate about a selective accumulation of pancuronium in the receptor compartment, 
these findings show that a direct blockade of prejunctional muscarinic receptors seems unlikely 
under these conditions.
Minette and Barnes (4) investigated the M2 receptor in human bronchus with the agonist 
pilocarpine but they could not find significant evidence for the M2 receptor with gallamine. The 
authors suggested that a residual concentration of atropine, which was used preoperatively, may 
be the cause of not reaching the level of significance with gallamine, The authors did not 
mention whether pancuronium or other muscle relaxants were used during anaesthesia. We 
could not find the prejunctional inhibitory muscarinic receptor in human bronchial smooth 
muscle with a series of selective antagonists either. One of the explanations suggested for the 
inability to identify inhibitory muscarinic receptors in human bronchus was that the anaesthetic 
drugs used during surgery may interfere with the experiments (10). Because of its 
antimuscarinic effects, pancuronium was considered to be of special interest (20,21).
Our study clearly demonstrates the influence of clinically relevant doses of pancuronium on the 
action of gallamine, although the mechanism underlying this phenomenon remains unknown. 
Clinical experiments by Minette el al. (9) indicated that prejunctional inhibitory muscarinic 
receptors may protect against parasympathetic stimuli in healthy subjects, whereas these 
receptors seemed to be dysfunctional in mild asthmatics. When pancuronium causes the 
inhibitory muscarinic receptor response to vanish in vivo and this receptor plays a protective 
role, one may wonder why the use of pancuronium in lung surgery has not resulted in any 
bronchospasms or asthmatic attacks. It might be interesting to focus coming investigations on 
this item.
The inihibitory muscarinic receptor is significantly less functional in presence of pancuronium, 
either intravenously administered or added to smooth muscle strips in the bath. Based on these 
results we expect that the administration of pancuronium during lung surgery has caused the 
apparent absence of muscarinic autoreceptors in our earlier experiments on human bronchus 
tissue. It will be interesting to compare pancuronium clinically as well as in animal experiments 
with other muscle relaxing agents without muscarinic activity (e.g. norcuronium).
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